February 28, 2015 1:41 AM ET

Pharmaceuticals

Company Overview of Semafore Pharmaceuticals, Inc.

Company Overview

Semafore Pharmaceuticals, Inc. discovers and develops clinical-stage drugs. It develops PI3 kinase and PTEN cell signaling pathway for multiple disorders, including cancer. Its PI3 kinase/PTEN cellular controls angiogenesis, apoptosis, migration, invasion, metastasis, and survival. The company’s products include SF1126, a PI3K Inhibitor Conjugate for prostate, breast, ovarian, renal, multiple myeloma, and other solid and hematological cancers, as well as cancers metastasized to bone; PI3K small-molecule inhibitors for cancer, inflammation, and other indications; and PTEN Inhibitors & Agonists for cell protection and therapeutic angiogenesis. Semafore Pharmaceuticals, Inc. was formerly known ...

8496 Georgetown Road

Indianapolis, IN 46268

United States

Founded in 2000

Phone:

317-876-3075

Fax:

317-876-3272

Key Executives for Semafore Pharmaceuticals, Inc.

Co-Founder, Chief Scientific Officer and Director
Acting Chief Medical Officer
Age: 68
Head of Business and Corporate Development
Age: 38
Medical Director and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
The Synergy Company of Utah, LLC United States
Barrier Therapeutics, Inc. United States
Novartis Consumer Health, Inc. United States
Nanotope, Inc. United States
PharmTak Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Semafore Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.